You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR ADCETRIS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ADCETRIS

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00848926 ↗	A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma	Completed	Millennium Pharmaceuticals, Inc.	Phase 2	2009-02-01	This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodgkin lymphoma.
NCT00848926 ↗	A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma	Completed	Seagen Inc.	Phase 2	2009-02-01	This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodgkin lymphoma.
NCT00848926 ↗	A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma	Completed	Seattle Genetics, Inc.	Phase 2	2009-02-01	This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodgkin lymphoma.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ADCETRIS

Condition Name

Chart
Table

Condition Name for ADCETRIS
Intervention	Trials
Hodgkin Lymphoma	14
Refractory Hodgkin Lymphoma	8
Recurrent Hodgkin Lymphoma	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ADCETRIS
Intervention	Trials
Lymphoma	72
Hodgkin Disease	50
Lymphoma, Non-Hodgkin	19
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ADCETRIS

Trials by Country

Map
Table

Trials by Country for ADCETRIS
Location	Trials
United States	527
Canada	30
Spain	18
United Kingdom	16
France	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ADCETRIS
Location	Trials
California	32
Texas	29
New York	26
Illinois	22
Washington	22
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ADCETRIS

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ADCETRIS
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	6
Phase 2	50
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ADCETRIS
Clinical Trial Phase	Trials
Completed	23
Recruiting	23
Active, not recruiting	18
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ADCETRIS

Sponsor Name

Chart
Table

Sponsor Name for ADCETRIS
Sponsor	Trials
Seagen Inc.	30
National Cancer Institute (NCI)	29
Seattle Genetics, Inc.	24
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ADCETRIS
Sponsor	Trials
Industry	80
Other	79
NIH	29
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.